Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets... see more

CSE:THC - Post Discussion

THC Biomed Intl Ltd > Provinces are requiring strains 20% explains the transition
View:
Post by RamboOO7 on Apr 02, 2022 8:49am

Provinces are requiring strains 20% explains the transition

During the three months ended January 31, 2022, the Company had sales revenue of $606,826 (January 31, 2021 - $1,021,989) which included excise taxes of $158,892 (January 31, 2021 - $303,307). This represents a decrease in sales revenue of 41% period to period. This decrease in revenue is associated with the decrease in the sale of dried cannabis. The provinces are requiring strains with tetrahydrocannabinol of at least 20% which prompted management to introduce the seven new strains to be launched on 4/20 of 2022. The Company will continue to concentrate on the sale of edibles going forward. Sales of edibles made up 39% of total sales. This shift to increasing the sale of edibles will ultimately increase our average selling price going forward, as evidenced by the recent launch of the THC Kiss Biscuits.
Comment by RamboOO7 on Apr 02, 2022 10:53am
Here it sales total edibles Q2 was $ 236,662.14. Almost same as Q1 so edibles sales didn't go down. Biscuits should have a good future impact. I am fed up of going through these financials. I guess i decided to wait for Q4. After no change i throw in the towel.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities